Status:

COMPLETED

Rapid Agitation Control With Ketamine in the Emergency Department

Lead Sponsor:

David Barbic

Collaborating Sponsors:

St Paul's Emergency Department Research Fund

Centre for Health Evaluation and Outcome Sciences (CHÉOS)

Conditions:

Violent Aggressive Behavior

Ketamine

Eligibility:

All Genders

19-60 years

Phase:

PHASE2

Brief Summary

Compare intramuscular (IM) ketamine to a combination of IM midazolam and haloperidol with regards to the time required for adequate behavioral control, in minutes, in patients presenting to the emerge...

Eligibility Criteria

Inclusion

  • Age 19 - 60 years inclusively;
  • Patients presenting to the emergency department with psychomotor agitation or violent behaviour (RASS score \> +3).

Exclusion

  • Less than 19 years of age;
  • Greater than 60 years of age;
  • Previous participation in this study;
  • Women suspected or known to be pregnant or breastfeeding;
  • Previous known hypersensitivity, intolerance or allergy to ketamine, midazolam or haloperidol or their components.
  • Subjects who are in comatose states or have CNS depression due to alcohol or are taking other depressant drugs.
  • Subjects with severe depressive states, spastic diseases and in Parkinson's syndrome, except in the case of dyskinesias due to levodopa treatment.
  • Senile patients with pre-existing Parkinson-like symptoms.
  • Subjects with a history of cerebrovascular accident
  • Subjects in whom a significant elevation of blood pressure would constitute a serious hazard, such as patients with significant hypertension
  • Subjects with severe cardiac decompensation
  • Subjects who intend to have surgery of the pharynx, larynx, or bronchial tree unless adequate muscle relaxants are used
  • Subjects with acute pulmonary insufficiency
  • Subjects with severe chronic obstructive pulmonary disease
  • Subjects with acute narrow angle glaucoma

Key Trial Info

Start Date :

May 29 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 12 2020

Estimated Enrollment :

81 Patients enrolled

Trial Details

Trial ID

NCT03375671

Start Date

May 29 2018

End Date

March 12 2020

Last Update

November 30 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

St. Paul's Hospital Emergency Department

Vancouver, British Columbia, Canada, V6Z 1Y6